Intelligent Bio Solutions Inc. Common Stock (INBS) is a publicly traded Healthcare sector company. As of May 21, 2026, INBS trades at $2.91 with a market cap of $8.73M and a P/E ratio of 0.34. INBS moved -11.85% today. Year to date, INBS is -74.27%; over the trailing twelve months it is -77.89%. Its 52-week range spans $2.27 to $27.50. Rallies surfaces INBS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for INBS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $2.91 |
| Market Cap | $8.73M |
| P/E Ratio | 0.34 |
| EPS | $8.95 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.50 |
| 52-Week Low | $2.27 |
| Volume | 169 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.91M |
| Net Income | $-11.65M |
| Gross Margin | 47.25% |
INBS analyst coverage data. Average price target: $0.00.